Kyowa Hakko News Releases 2001
- December 26, 2001
- Kyowa Hakko has developed
a new antibody technology
Initiating an aggressive approach
to therapeutic antibody business - December 6, 2001
- Phase Ⅱ clinical study of
an anti-cancer agent
KW-2170
will start in five countries including the US. - November 14, 2001
- Kyowa Hakko Announces
Consolidated Earnings for
First-Half of Fiscal 2001 - November 1, 2001
- Kyowa Hakko Opens
'Specialty Chemicals Online'
Website to Provide
as Functional Food Ingredient - October 25, 2001
- Kyowa Hakko Announces Revision to Forecast of Consolidated and
Non-consolidated Results for Year Ending March 2002
-- Also announces recording of extraordinary profit and loss
(25KB) - August 23, 2001
- CSPHP “SUPERSOY” Presentation
to highlight International Congress
of Nutrition 2001 technical session - June 25, 2001
- Features Suitability of Cholesterol-lowering
CSPHP Soy Peptide
as Functional Food Ingredient
at IFT Expo 2001 - June 21, 2001
- Use of CSPHP Soy Peptide
as Functional Food Ingredient
at IFT Expo 2001
Will include detailed explanation of
cholesterol-lowering properties of CSPHP - June 6, 2001
- KW-7158,
a therapeutic agent for urinary incontinence,
will enter Phase Ⅱ in Europe - April 25, 2001
- Kyowa Hakko's vision
of pharmaceutical business,
“Reform for value creation” - April 23, 2001
- Kyowa Hakko Starts Marketing
Cholesterol-Lowering Super Soy in the U.S., Europe - March 5, 2001
- New antiallergic agent “Allelock” launched
- You need Adobe® Reader® to view these documents.
Download Adobe® Reader® of Adobe Systems here.
